Principal Financial Group Inc. reduced its position in Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 49.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 57,385 shares of the company's stock after selling 55,102 shares during the quarter. Principal Financial Group Inc. owned about 0.60% of Semler Scientific worth $2,077,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also made changes to their positions in the company. Capital International Investors acquired a new stake in shares of Semler Scientific during the fourth quarter valued at about $30,813,000. Susquehanna Advisors Group Inc. acquired a new position in Semler Scientific in the fourth quarter worth about $26,928,000. Driehaus Capital Management LLC acquired a new position in Semler Scientific in the fourth quarter worth about $10,122,000. Geode Capital Management LLC grew its stake in Semler Scientific by 3.3% in the fourth quarter. Geode Capital Management LLC now owns 140,423 shares of the company's stock worth $7,584,000 after purchasing an additional 4,464 shares in the last quarter. Finally, Nuveen Asset Management LLC grew its stake in Semler Scientific by 396.9% in the fourth quarter. Nuveen Asset Management LLC now owns 124,548 shares of the company's stock worth $6,726,000 after purchasing an additional 99,482 shares in the last quarter. 49.37% of the stock is owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on SMLR. Benchmark started coverage on Semler Scientific in a research note on Tuesday, July 8th. They issued a "buy" rating and a $101.00 target price for the company. Wall Street Zen cut Semler Scientific from a "buy" rating to a "sell" rating in a report on Thursday, May 22nd. Finally, Maxim Group raised Semler Scientific to a "strong-buy" rating and set a $95.00 price target on the stock in a report on Wednesday, July 9th.
Get Our Latest Stock Analysis on Semler Scientific
Semler Scientific Price Performance
Semler Scientific stock traded down $2.36 during mid-day trading on Friday, hitting $41.24. The company's stock had a trading volume of 622,725 shares, compared to its average volume of 580,570. Semler Scientific Inc. has a twelve month low of $21.77 and a twelve month high of $81.56. The company has a quick ratio of 0.51, a current ratio of 0.52 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $564.49 million, a P/E ratio of -15.80 and a beta of 1.39. The stock's fifty day moving average price is $38.38 and its two-hundred day moving average price is $41.29.
Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its quarterly earnings data on Tuesday, May 13th. The company reported ($0.76) earnings per share for the quarter. The firm had revenue of $8.84 million for the quarter. Semler Scientific had a positive return on equity of 19.75% and a negative net margin of 60.69%.
About Semler Scientific
(
Free Report)
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.
Further Reading

Before you consider Semler Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.
While Semler Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.